Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV005005136 | SCV002779306 | uncertain significance | Bone mineral density quantitative trait locus 1; Exudative vitreoretinopathy 4; Worth disease; Autosomal dominant osteopetrosis 1; Osteoporosis with pseudoglioma; Polycystic liver disease 4 with or without kidney cysts | 2024-05-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002541754 | SCV002944214 | uncertain significance | not provided | 2022-10-25 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 992381). This variant has not been reported in the literature in individuals affected with LRP5-related conditions. This variant is present in population databases (rs770787447, gnomAD 0.01%). This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 1100 of the LRP5 protein (p.Gly1100Ser). |
Bioscientia Institut fuer Medizinische Diagnostik Gmb |
RCV001280820 | SCV001468160 | uncertain significance | Polycystic liver disease 4 with or without kidney cysts | 2019-12-16 | no assertion criteria provided | clinical testing |